1. Fleming DT, McQuillan, GM, Johnson, RE, et al. Herpes Simplex Virus Type 2 in the United States. NEJM 1997; 337: 1105-1111

2. Leone P, Fleming D, Gilsenan AW, et al. Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States. Sex Trans Dis 2004; 31: 311-16

3. Langenberg A, Corey L, Ashley R, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. NEJM 1999;341:1432-1438

4. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2006. MMWR 2006; 55 (No. RR-11): 1 to 100

5. American Social Health Association. Sexually Transmitted Diseases in America: How many and at what cost? 1998

6. Smith PD, Roberts CM. American college health association annual pap test and sexually transmitted infection survey: 2006. J Am Coll Health 2009 Jan-Feb; 57(4): 389-94

7. Engleberg R, Carrell D, Krantz E, et al. Natural history of genital herpes simplex virus type 1 infection. Sex Trans Dis 2003; 30: 174-7

8. Xu F, Steenberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006;296:964-973

9. Ashley RL, Corey L. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus. J Clin Invest 1984; 73: 1-8

10. Song B, Dwyer DE, Mindel A. HSV type specific serology in sexual health clinics: use, benefits, and who gets tested. Sex Transm Infect 2004; 80: 113-117

11. Morrow RA, Brown ZA. Common use of inaccurate antibody assays to identify infection status with herpes simplex virus type 2. Am J Obstet Gynecol 2005; 193: 361-2

12. Ashley RL. Performance and use of HSV type-specific serology test kits. Herpes 2002; 9(2): 38-45

13. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis 2003 Apr;30(4):310-4

14. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomology, diagnosis, and management. J Am Acad Dermatol 2007; 57(5): 737-63; quiz 764-6

15. Bryson YJ, Dillon M, Bernstein D, et al. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993; 167: 942-6

16. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333: 770-5

17. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98: 958-72

18. Schmidt OW, Fife KH, Corey L. Reinfection is an uncommon occurance in patients with symptomatic recurrent genital herpes. JID 1984; 149: 645-6

19. Wald A, Krantz E, Selke S, et al. Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis 2006Jul 1; 194(1): 42-52